B47.1
Actinomycetoma
Clinical Classification Guidelines
Medical Intelligence & Overview
Actinomycetoma, classified under ICD-10 code B47.1, is a chronic bacterial infection characterized by the formation of nodules, abscesses, and sinus tracts that often discharge pus containing characteristic grains. It primarily affects the skin, subcutaneous tissues, and sometimes deeper structures, predominantly occurring in tropical and subtropical regions. This condition is part of a broader group of diseases known as mycetoma, distinguished by their causative agents, with actinomycetoma caused specifically by bacteria of the actinomycete group.
Causes & Symptoms
Clinical Causes: Infection caused by filamentous bacteria known as actinomycetes, including species like Nocardia, Actinomadura, and Streptomyces. Typically transmitted through traumatic implantation of bacteria into the skin, often via thorn pricks, cuts, or other injuries involving soil or plant material. Unsanitary or poor living conditions that increase exposure to contaminated soil or organic matter.
Key Symptoms: Localized swelling or nodules that gradually enlarge over time. Formation of abscesses and sinus tracts, which may drain pus. Presence of characteristic grains or granules in the discharge, often appearing as small, creamy or yellowish clumps. Skin ulcers and tissue destruction in advanced cases. Possible involvement of underlying bones or joints if the infection spreads or is left untreated. Minimal systemic symptoms in early stages, but prolonged infections can lead to fever or malaise.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of actinomycetoma typically involves a combination of clinical evaluation and laboratory tests. Clinicians may perform skin biopsies or fine-needle aspiration to obtain tissue samples. Microbiological examinations, including direct microscopy to identify characteristic grains, culture on specific media to grow bacteria, and histopathology, are essential. Imaging studies, such as X-rays, MRI, or ultrasound, assist in evaluating the extent of tissue and bone involvement. Identification of the causative bacteria guides targeted treatment.
Treatment Protocols: Management of actinomycetoma generally requires prolonged antibiotic therapy tailored to the specific bacterial species involved. Commonly used antibiotics include sulfonamides, dapsone, and other combination therapies. In some cases, surgical intervention may be necessary to remove abscesses, sinus tracts, or necrotic tissue. Consistent follow-up and adherence to the prescribed treatment plan are crucial to prevent recurrence and achieve complete resolution. Addressing underlying factors like wound care and environmental exposure is also important in preventing future infections.
Clinical Advice & FAQs
Billing Guidance
Is B47.1 a billable ICD-10 code?
Yes, B47.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B47.1?
Clinical documentation must specify the nature of Actinomycetoma and any associated comorbidities for accurate reporting.
Cite this Clinical Reference